Boiron SA
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products, including medical devices, invitro diagnostics, herbal medicine, food supplements, cosmetics, and CBD-based products. It also provides homeopathic specialties compr… Read more
Boiron SA - Asset Resilience Ratio
Boiron SA (BOI) has an Asset Resilience Ratio of -0.13% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2001–2023)
This chart shows how Boiron SA's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Boiron SA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €-747.00K | -0.13% |
| Total Liquid Assets | €-747.00K | -0.13% |
Asset Resilience Insights
- Limited Liquidity: Boiron SA maintains only -0.13% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Boiron SA Industry Peers by Asset Resilience Ratio
Compare Boiron SA's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF |
Drug Manufacturers - Specialty & Generic | -0.02% |
|
Kamada
NASDAQ:KMDA |
Drug Manufacturers - Specialty & Generic | 21.63% |
|
Dongwha Pharm.Co.Ltd
KO:000020 |
Drug Manufacturers - Specialty & Generic | 1.92% |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078 |
Drug Manufacturers - Specialty & Generic | 0.46% |
|
Yuhan Corp.
KO:000100 |
Drug Manufacturers - Specialty & Generic | 0.99% |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153 |
Drug Manufacturers - Specialty & Generic | 1.81% |
|
Kotra Industries Bhd
KLSE:0002 |
Drug Manufacturers - Specialty & Generic | 9.82% |
|
Yuyu Pharma Inc
KO:000227 |
Drug Manufacturers - Specialty & Generic | 1.74% |
Annual Asset Resilience Ratio for Boiron SA (2001–2023)
The table below shows the annual Asset Resilience Ratio data for Boiron SA.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | -0.13% | €-747.00K | €590.20 Million | -0.09pp |
| 2022-12-31 | -0.03% | €-260.00K | €789.49 Million | +0.02pp |
| 2021-12-31 | -0.05% | €-398.00K | €770.70 Million | 0.00pp |
| 2020-12-31 | -0.05% | €-397.00K | €781.82 Million | +0.00pp |
| 2019-12-31 | -0.05% | €-411.00K | €764.28 Million | -0.06pp |
| 2015-12-31 | 0.01% | €41.00K | €695.45 Million | +0.49pp |
| 2012-12-31 | -0.48% | €-2.79 Million | €579.28 Million | -0.92pp |
| 2001-12-31 | 0.44% | €905.00K | €205.86 Million | -- |